AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200 million ($271 million) expansion of its Cambridge research site. The move, which would have created up to 1,000 jobs, highlights growing tensions between the pharmaceutical industry and the UK government over…
With US equities hovering near record levels and economics indicators flashing warning signs – Morgan Stanley is urging investors…
Markets ended the week with a mix of corporate developments, economic data, and breaking news shaping investor sentiment. Tesla…
The world’s largest asset manager is set to use President Donald Trump’s state visit to the United Kingdom next…
The final pieces of the puzzle have fallen into place, and the verdict is in: the Federal Reserve is…
A day of significant developments is underway across the Asia-Pacific, as a Wall Street giant makes a key strategic…
The International Energy Agency reported on Friday that the projected development of low-emissions hydrogen projects by 2030 has decreased…
Gold’s price action offers significant insights into the global economy and financial markets, demonstrating that it is more than…
Vietnamese authorities have confirmed a cyberattack on the National Credit Information Center (CIC), raising concerns about the safety of…